For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

News

The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi institution teams to advance their groundbreaking cancer research projects. The grants will support studies on mechanisms that drive lymphoma and urothelial cancers, and the effects of radiation therapy.

Established by the Starr Foundation in 2006, the Starr Cancer Consortium is a collaboration among five leading research institutions: The Broad Institute of MIT and Harvard, Cold Spring...

Read More

A new test for measuring the reservoir of HIV hidden in the cells of people with HIV failed to detect this reservoir in a significant number of people with a subtype of HIV-1, according to a study from scientists at Weill Cornell Medicine, Simon Fraser University and the British Columbia Centre for Excellence in HIV/AIDS. Modifications to the test, which is frequently used in clinical trials for new HIV-1 treatments and potential cures, could potentially improve its utility....

Read More


Mutations in proteins called histone H1, which help package DNA in chromosomes, are a frequent cause of lymphomas, according to a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and The Rockefeller University. The findings could lead to new approaches to treating these cancers.

Scientists in recent years have observed that mutations in histone H1 genes occur in lymphomas, but they have not known whether these mutations are causes...

Read More

Space travel, illnesses like COVID-19, and climbing Mount Everest can trigger the body’s stress response systems in similar ways, according to new studies by Weill Cornell Medicine, space agencies and many other investigators. The discoveries, including new maps of the abundance of mutations and immune changes found in blood cells during spaceflight, may lead to new ways to protect space travelers. They may also provide insights on caring for Earth-bound patients with illnesses that trigger...

Read More

Common symptoms of the genetic disorder neurofibromatosis type 1 (NF1), including skeletal fragility and the loss of bone mass, may be treatable with an existing anti-cancer drug, according to a study from researchers at Weill Cornell Medicine. The findings reveal the potential for an expanding array of therapeutic options for patients who have this difficult-to-treat condition.

The study, published Nov. 11 in Nature Communications, uncovered a signaling...

Read More

A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases, according to a study by investigators at Weill Cornell Medicine.

A study published in Nature on July 22 found that when a chemical tag composed of a phosphate group is added to H3.3, one of the spool-like histone proteins that condense DNA and control...

Read More

Video of Weill Cornell Medicine Class of 2020 Celebrates with Virtual Commencement

Like more than half of Weill Cornell Medicine’s Class of 2020, Dr. Kevin Ackerman chose to graduate early to be of service to New York City’s healthcare system during the COVID-19 pandemic. After the quick transition to working in the field in April, he relished the opportunity Commencement afforded to mark the end of his medical education and reflect on why he chose medicine as his career. 

“...

Read More

The Weill Cornell Graduate School of Medical Sciences honored the Class of 2020 for their academic achievements during a virtual convocation ceremony on May 27. Students and their families and friends watched a livestream of the event, as graduate school faculty announced the recipients of special awards and prizes.

“Convocation this year certainly looks different than our normal celebration, but with the current challenges of COVID-19, it is all the more important to recognize the...

Read More

Dr. Kornelia Polyak, Ph.D. ’95, a professor of medicine at the Dana-Farber Cancer Institute and Harvard Medical School, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.

Graduate school alumni have been recognized with this award since 1997 for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to society.

“I’m very honored...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-5981